Search: WFRF:(Boutron Ruault Marie Christine) > (2020-2024) > Exogenous hormone u...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05952naa a2200985 4500 | |
001 | oai:DiVA.org:umu-170565 | |
003 | SwePub | |
008 | 200511s2020 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:dcfd448f-f82c-40be-aee2-8c890ba65a37 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1705652 URI |
024 | 7 | a https://doi.org/10.1002/ijc.326742 DOI |
024 | 7 | a https://lup.lub.lu.se/record/dcfd448f-f82c-40be-aee2-8c890ba65a372 URI |
040 | a (SwePub)umud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Cervenka, Irisu Institut Gustave Roussy,University of Paris-Saclay4 aut |
245 | 1 0 | a Exogenous hormone use and cutaneous melanoma risk in women :b The European Prospective Investigation into Cancer and Nutrition |
264 | c 2019-10-10 | |
264 | 1 | b John Wiley & Sons,c 2020 |
338 | a print2 rdacarrier | |
520 | a Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country‐specific self‐administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline‐significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a cohort studies | |
653 | a cutaneous melanoma | |
653 | a epidemiology | |
653 | a hormonal treatments | |
653 | a menopausal hormone therapy | |
653 | a oral contraceptives | |
653 | a cohort studies | |
653 | a cutaneous melanoma | |
653 | a epidemiology | |
653 | a hormonal treatments | |
653 | a menopausal hormone therapy | |
653 | a oral contraceptives | |
700 | 1 | a Al Rahmoun, Marie4 aut |
700 | 1 | a Mahamat-Saleh, Yahya4 aut |
700 | 1 | a Fournier, Agnes4 aut |
700 | 1 | a Boutron-Ruault, Marie-Christine4 aut |
700 | 1 | a Severi, Gianluca4 aut |
700 | 1 | a Caini, Saverio4 aut |
700 | 1 | a Palli, Domenico4 aut |
700 | 1 | a Ghiasvand, Reza4 aut |
700 | 1 | a Veierod, Marit B.4 aut |
700 | 1 | a Botteri, Edoardo4 aut |
700 | 1 | a Tjonneland, Anne4 aut |
700 | 1 | a Olsen, Anja4 aut |
700 | 1 | a Fortner, Renee T.4 aut |
700 | 1 | a Kaaks, Rudolf4 aut |
700 | 1 | a Schulze, Matthias B.4 aut |
700 | 1 | a Panico, Salvatore4 aut |
700 | 1 | a Trichopoulou, Antonia4 aut |
700 | 1 | a Dessinioti, Clio4 aut |
700 | 1 | a Niforou, Katerina4 aut |
700 | 1 | a Sieri, Sabina4 aut |
700 | 1 | a Tumino, Rosario4 aut |
700 | 1 | a Sacerdote, Carlotta4 aut |
700 | 1 | a Bueno-de-Mesquita, Bas4 aut |
700 | 1 | a Sandanger, Torkjel M.4 aut |
700 | 1 | a Colorado-Yohar, Sandra4 aut |
700 | 1 | a Sanchez, Maria J.4 aut |
700 | 1 | a Gil Majuelo, Leire4 aut |
700 | 1 | a Lujan-Barroso, Leila4 aut |
700 | 1 | a Ardanaz, Eva4 aut |
700 | 1 | a Merino, Susana4 aut |
700 | 1 | a Isaksson, Karolinu Lund University,Lunds universitet,Lunds Melanomstudiegrupp,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Lund Melanoma Study Group,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital4 aut0 (Swepub:lu)kir-kis |
700 | 1 | a Butt, Salmau Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups4 aut0 (Swepub:lu)med-smb |
700 | 1 | a Ljuslinder, Ingrid4 aut |
700 | 1 | a Jansson, Malinu Umeå universitet,Kirurgi4 aut0 (Swepub:umu)manjan00 |
700 | 1 | a Travis, Ruth C.4 aut |
700 | 1 | a Khaw, Kay-Tee4 aut |
700 | 1 | a Weiderpass, Elisabete4 aut |
700 | 1 | a Dossus, Laure4 aut |
700 | 1 | a Rinaldi, Sabina4 aut |
700 | 1 | a Kvaskoff, Marinau University of Paris-Saclay,Institut Gustave Roussy4 aut |
710 | 2 | a Institut Gustave Roussyb University of Paris-Saclay4 org |
710 | 2 | a et al. |
773 | 0 | t International Journal of Cancerd : John Wiley & Sonsg 146:12, s. 3267-3280q 146:12<3267-3280x 0020-7136x 1097-0215 |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32674 |
856 | 4 | u http://dx.doi.org/10.1002/ijc.32674y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-170565 |
856 | 4 8 | u https://doi.org/10.1002/ijc.32674 |
856 | 4 8 | u https://lup.lub.lu.se/record/dcfd448f-f82c-40be-aee2-8c890ba65a37 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view